| Name | Title | Contact Details |
|---|
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
Flex America is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bridgeway Care Ctr is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Outcome Resources is a Rocklin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
America's PPO is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.